References
- Millar FA, Simmonds NJ, Hodson ME. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005. J Cyst Fibros 2009;8:386–91.
- Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012;25:2–41.
- Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998;11:57–80.
- Church D, Lloyd T, Peirano G, Pitout J. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates. Scand J Infect Dis 2013; 45:265–70.
- CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Third Informational Supplement. CLSI document M100 – S23. Clinical and Laboratory Standards Institute; 2013.
- Mathew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focussing for detection and identification of beta-lactamases. J Gen Microbiol 1975;88:169–78.
- Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U. A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae causing nosocomial pneumonia. Antimicrob Agents Chemother 1999;43: 1924–31.
- Heinar P, Kolar M, Chmela Z. Double-disc synergy test positivity in Stenotrophomonas maltophilia clinical strains. Folia Microbiol (Praha) 2004;49:71–4.
- Markovska R, Schneider I, Keuleyan E, Sredkova M, Ivanova D, Markova B, et al. Extended-spectrum beta- lactamase-producing Enterobacteriaceae in Bulgarian hospitals. Microb Drug Resist 2008;14:119–28.
- Yao JD, Conly JM, Krajden M. Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J Clin Microbiol 1995;33:2195–8.